Heather Bresch, chief executive officer of Mylan NV, speaks during a Bloomberg Television interview in New York, U.S., on Thursday, Aug. 6, 2015. Bresch discussed the generic drugmaker’s second-quarter profit and share price, mergers and acquisitions in the pharmaceutical industry, the failed takeover bid for Mylan by Teva Pharmaceuticals Industries Ltd. and Mylan’s own bid for Perrigo Co. Photographer: Chris Goodney/Bloomberg via Getty Images